Dexcom () has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock hedge fund-level data and powerful investing tools for smarter ...
Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street estimates for ...
DexCom (NASDAQ: DXCM) held its first-quarter earnings conference call on Thursday. Below is the complete transcript from the ...
Q1 2026 earnings call: 15% revenue growth, Prime coverage expansion, G7 15 Day rollout, and raised margin outlook.
Senseonics has launched its Eversense 365 continuous glucose monitoring system in Europe, offering a sensor lifespan of one year. The rollout starts in Sweden, with Germany, Spain, and Italy to follow ...
StockStory.org on MSN
DXCM Q1 deep dive: US growth moderates as product momentum and coverage expansion drive strategy
Medical device company DexCom (NASDAQ:DXCM) reported Q1 CY2026 results , with sales up 15% year on year to $1.19 billion. The ...
Wearable technology makes it easier to track health metrics. Ask Dr. Denise Dennis-Coke about health-tracking devices, and she’ll show you the ones she’s wearing. “I have on my Dexcom Stelo, my Oura ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results